相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Stable IgG-like Bispecific Antibodies Directed toward the Type I Insulin-like Growth Factor Receptor Demonstrate Enhanced Ligand Blockade and Anti-tumor Activity
Jianying Dong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Biodistribution Mechanisms of Therapeutic Monoclonal Antibodies in Health and Disease
Mohammad Tabrizi et al.
AAPS JOURNAL (2010)
Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimization
Kiyotaka Nakano et al.
ANTI-CANCER DRUGS (2010)
Prediction of Immunogenicity of Therapeutic Proteins Validity of Computational Tools
Christine J. Bryson et al.
BIODRUGS (2010)
Structure-Guided Design of Antibodies
Justin A. Caravella et al.
Current Computer-Aided Drug Design (2010)
Glutamine-linked and Non-consensus Asparagine-linked Oligosaccharides Present in Human Recombinant Antibodies Define Novel Protein Glycosylation Motifs
John F. Valliere-Douglass et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
De Novo Selection of High-Affinity Antibodies from Synthetic Fab Libraries Displayed on Phage as pIX Fusion Proteins
Lei Shi et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Engineering Fully Human Monoclonal Antibodies from Murine Variable Regions
Matthew J. Bernett et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Factors Affecting the Viscosity in High Concentration Solutions of Different Monoclonal Antibodies
Sandeep Yadav et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
The immunogenicity of humanized and fully human antibodies Residual immunogenicity resides in the CDR regions
Fiona A. Harding et al.
MABS (2010)
Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization
Tomoyuki Igawa et al.
NATURE BIOTECHNOLOGY (2010)
Enhanced antibody half-life improves in vivo activity
Jonathan Zalevsky et al.
NATURE BIOTECHNOLOGY (2010)
Stability engineering of scFvs for the development of bispecific and multivalent antibodies
Brian R. Miller et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
Structure-based engineering of a monoclonal antibody for improved solubility
Sheng-Jiun Wu et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
Reduced elimination of IgG antibodies by engineering the variable region
T. Igawa et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
Increased aggregation propensity of IgG2 subclass over IgG1: Role of conformational changes and covalent character in isolated aggregates
Heather Franey et al.
PROTEIN SCIENCE (2010)
Monoclonal antibodies: versatile platforms for cancer immunotherapy
Louis M. Weiner et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Therapeutic antibodies for autoimmunity and inflammation
Andrew C. Chan et al.
NATURE REVIEWS IMMUNOLOGY (2010)
T cell epitope: Friend or Foe? Immunogenicity of biologics in context
Constanze A. Weber et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody
Josef Vlasak et al.
ANALYTICAL BIOCHEMISTRY (2009)
Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis
T. R. D. J. Radstake et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Improving the species cross-reactivity of an antibody using computational design
Christopher J. Farady et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Optimization of Fc-mediated effector functions of monoclonal antibodies
William R. Strohl
CURRENT OPINION IN BIOTECHNOLOGY (2009)
Mammalian meat-induced anaphylaxis: Clinical relevance of anti-galactose-α-1,3-galactose IgE confirmed by means of skin tests to cetuximab
Sandrine Jacquenet et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Succinimide Formation at Asn 55 in the Complementarity Determining Region of a Recombinant Monoclonal Antibody IgG1 Heavy Chain
Boxu Yan et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTβR
Jennifer S. Michaelson et al.
MABS (2009)
Specificity tuning of antibody fragments to neutralize two human chemokines with a single agent
Severine Fagete et al.
MABS (2009)
Molecular construction and optimization of anti-human IL-1α/β dual variable domain immunoglobulin (DVD-Ig™) molecules
Chengbin Wu et al.
MABS (2009)
The influence of the framework core residues on the biophysical properties of immunoglobulin heavy chain variable domains
Annemarie Honegger et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2009)
Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site
Jenny Bostrom et al.
SCIENCE (2009)
Use of quantitative pharmacology in the development of HAE1, a high-affinity anti-IgE monoclonal antibody
Wendy S. Putnam et al.
AAPS JOURNAL (2008)
Immunogenicity negatively influences the outcome of adalimumab treatment in Crohn's disease
R. L. West et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Activation of natural regulatory T cells by IgG Fc-derived peptide Tregitopes
Anne S. De Groot et al.
BLOOD (2008)
Fully human antibodies from transgenic mouse and phage display platforms
Nils Lonberg
CURRENT OPINION IN IMMUNOLOGY (2008)
Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates
Anne S. De Groot et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Ig-chain shuffling for affinity maturation of phage library-derived human anti-human MCP-1 antibody blocking its chemotactic activity
Keisuke Yoshinaga et al.
JOURNAL OF BIOCHEMISTRY (2008)
The potency of erythropoietin-mimic antibodies correlates inversely with affinity
Susan E. Lacy et al.
JOURNAL OF IMMUNOLOGY (2008)
Germline Humanization of a Non-human Primate Antibody that Neutralizes the Anthrax Toxin, by in Vitro and in Silico Engineering
Thibaut Pelat et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab-Fab interaction that impacts solution viscosity
Sonoko Kanai et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Removal of cysteinylation from an unpaired sulfhydryl in the variable region of a recombinant monoclonal IgG1 antibody improves homogeneity, stability, and biological activity
Douglas D. Banks et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Heterogeneity of monoclonal antibodies
Hongcheng Liu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Affinity maturation of antibodies assisted by in silico modeling
Rodrigo Barderas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
New Approaches to Prediction of Immune Responses to Therapeutic Proteins during Preclinical Development
Laura C. A. Perry et al.
DRUGS IN R&D (2008)
Computational design of antibody-affinity improvement beyond in vivo maturation
Shaun M. Lippow et al.
NATURE BIOTECHNOLOGY (2007)
Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis
Geertje M. Bartelds et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Clinical validation of the in silico prediction of immunogenicity of a human recombinant therapeutic protein
E. Koren et al.
CLINICAL IMMUNOLOGY (2007)
Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract
Herren Wu et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
A broad range of Fab stabilities within a host of therapeutic IgGs
Ellen Garber et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Identification of a single tryptophan residue as critical for binding activity in a humanized monoclonal antibody against respiratory syncytial virus
Ziping Wei et al.
ANALYTICAL CHEMISTRY (2007)
Process economics of industrial monoclonal antibody manufacture
Suzanne S. Farid
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Immunogenicity, efficacy and adverse events of adalimumab in RA patients
Niko K. Bender et al.
RHEUMATOLOGY INTERNATIONAL (2007)
Antibody structure, instability, and formulation
Wei Wang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin
Consuelo Garcia-Rodriguez et al.
NATURE BIOTECHNOLOGY (2007)
Regulation of antibody-dependent cellular cytotoxicity by IgG intrinsic and apparent affinity for target antigen
Yong Tang et al.
JOURNAL OF IMMUNOLOGY (2007)
Immunogenicity screening in protein drug development
Ivo Van Walle et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
In vitro evolution of single-chain antibodies using mRNA display
Isao Fukuda et al.
NUCLEIC ACIDS RESEARCH (2006)
Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn)
William F. Dall'Acqua et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design
LA Clark et al.
PROTEIN SCIENCE (2006)
Construction, affinity maturation, and biological characterization of an anti-tumor-associated glycoprotein-72 humanized antibody
SO Yoon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Ribosome display for improved biotherapeutic molecules
A Rothe et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2006)
An engineered human IgG1 antibody with longer serum half-life
PR Hinton et al.
JOURNAL OF IMMUNOLOGY (2006)
Effects of protein aggregates: An immunologic perspective
Amy S. Rosenberg
AAPS JOURNAL (2006)
Elimination mechanisms of therapeutic monoclonal antibodies
MA Tabrizi et al.
DRUG DISCOVERY TODAY (2006)
Demonstration of an in vivo generated sub-picomolar affinity fully human monoclonal antibody to interleukin-8
P Rathanaswami et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Fine tuning of the specificity of an anti-progesterone antibody by first and second sphere residue engineering
O Dubreuil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A general method for greatly improving the affinity of antibodies by using combinatorial libraries
A Rajpal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
SDR grafting - a new approach to antibody humanization
SVS Kashmiri et al.
METHODS (2005)
Immunogenicity of engineered antibodies
WYK Hwang et al.
METHODS (2005)
Use of human germline genes in a CDR homology-based approach to antibody humanization
WYK Hwang et al.
METHODS (2005)
Domain interactions in the Fab fragment:: A comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability
D Röthlisberger et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Protein aggregation and its inhibition in biopharmaceutics
W Wang
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Human antibodies from transgenic animals
N Lonberg
NATURE BIOTECHNOLOGY (2005)
Selecting and screening recombinant antibody libraries
HR Hoogenboom
NATURE BIOTECHNOLOGY (2005)
Minimizing the immunogenicity of protein therapeutics
AJ Chirino et al.
DRUG DISCOVERY TODAY (2004)
Engineering of a broad specificity antibody for simultaneous detection of 13 sulfonamides at the maximum residue level
T Korpimäki et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2004)
Stability improvement of antibodies for extracellular and intracellular applications:: CDR grafting to stable frameworks and structure-based framework engineering
S Ewert et al.
METHODS (2004)
SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity
NR Gonzales et al.
MOLECULAR IMMUNOLOGY (2004)
Challenges in the development of high protein concentration formulations
SJ Shire et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Antibody pharmacokinetics and pharmacodynamics
ED Lobo et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Biophysical properties of human antibody variable domains
S Ewert et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Further improvement of broad specificity hapten recognition with protein engineering
T Korpimaki et al.
PROTEIN ENGINEERING (2003)
Rationally engineered proteins or antibodies with absent or reduced immunogenicity
S Tangri et al.
CURRENT MEDICINAL CHEMISTRY (2002)
Improving broad specificity hapten recognition with protein engineering
T Korpimäki et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2002)
Superhumanized antibodies: Reduction of immunogenic potential by complementarity-determining region grafting with human germline sequences: Application to an anti-CD28
P Tan et al.
JOURNAL OF IMMUNOLOGY (2002)
Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity
JA Maynard et al.
NATURE BIOTECHNOLOGY (2002)
Altering the fine specificity of an anti-Legionella single chain antibody by a single amino acid insertion
BJ McCarthy et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Molecular clocks
NE Robinson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Picomolar affinity antibodies from a fully synthetic naive library selected and evolved by ribosome display
J Hanes et al.
NATURE BIOTECHNOLOGY (2000)
Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity
ET Boder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Structural correlates of an anticarcinoma antibody: Identification of specificity-determining residues (SDRs) and development of a minimally immunogenic antibody variant by retention of SDRs only
M Tamura et al.
JOURNAL OF IMMUNOLOGY (2000)
Effect of somatic hypermutation on potential N-glycosylation sites in human immunoglobulin heavy chain variable regions
D Dunn-Walters et al.
MOLECULAR IMMUNOLOGY (2000)
分享论文
